90 related articles for article (PubMed ID: 21105576)
1. Ethosomes for the delivery of anti-HSV-1 molecules: preparation, characterization and in vitro activity.
Cortesi R; Ravani L; Zaid AN; Menegatti E; Romagnoli R; Drechsler M; Esposito E
Pharmazie; 2010 Oct; 65(10):743-9. PubMed ID: 21105576
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy.
Lembo D; Swaminathan S; Donalisio M; Civra A; Pastero L; Aquilano D; Vavia P; Trotta F; Cavalli R
Int J Pharm; 2013 Feb; 443(1-2):262-72. PubMed ID: 23279938
[TBL] [Abstract][Full Text] [Related]
3. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.
Zhou Y; Wei YH; Zhang GQ; Wu XA
Arch Pharm Res; 2010 Apr; 33(4):567-74. PubMed ID: 20422366
[TBL] [Abstract][Full Text] [Related]
4. Colloidal dispersions for the delivery of acyclovir: a comparative study.
Cortesi R; Ravani L; Menegatti E; Drechsler M; Esposito E
Indian J Pharm Sci; 2011 Nov; 73(6):687-93. PubMed ID: 23112407
[TBL] [Abstract][Full Text] [Related]
5. Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study.
Esposito E; Menegatti E; Cortesi R
J Cosmet Sci; 2004; 55(3):253-64. PubMed ID: 15264053
[TBL] [Abstract][Full Text] [Related]
6. Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections.
Sicurella M; Pula W; Musiał K; Cieślik-Boczula K; Sguizzato M; Bondi A; Drechsler M; Montesi L; Esposito E; Marconi P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835541
[TBL] [Abstract][Full Text] [Related]
7. Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir.
Cortesi R; Ajanji SC; Sivieri E; Manservigi M; Fundueanu G; Menegatti E; Esposito E
J Microencapsul; 2007 Aug; 24(5):445-56. PubMed ID: 17578734
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.
Jain S; Tiwary AK; Sapra B; Jain NK
AAPS PharmSciTech; 2007 Dec; 8(4):E111. PubMed ID: 18181532
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of acyclovir-loaded flexible membrane vesicles (FMVs): evidence of preclinical efficacy of antiviral activity in murine model of cutaneous HSV-1 infection.
Sharma G; Thakur K; Setia A; Amarji B; Singh MP; Raza K; Katare OP
Drug Deliv Transl Res; 2017 Oct; 7(5):683-694. PubMed ID: 28801835
[TBL] [Abstract][Full Text] [Related]
11. Nano and microparticulate chitosan-based systems for antiviral topical delivery.
Calderón L; Harris R; Cordoba-Diaz M; Elorza M; Elorza B; Lenoir J; Adriaens E; Remon JP; Heras A; Cordoba-Diaz D
Eur J Pharm Sci; 2013 Jan; 48(1-2):216-22. PubMed ID: 23159663
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of sponge-like acyclovir ocular minitablets.
Refai H; Tag R
Drug Deliv; 2011 Jan; 18(1):38-45. PubMed ID: 20804440
[TBL] [Abstract][Full Text] [Related]
13. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
[TBL] [Abstract][Full Text] [Related]
14. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases.
Bhalaria MK; Naik S; Misra AN
Indian J Exp Biol; 2009 May; 47(5):368-75. PubMed ID: 19579803
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/poly(amidoamine) copolymer.
Bencini M; Ranucci E; Ferruti P; Trotta F; Donalisio M; Cornaglia M; Lembo D; Cavalli R
J Control Release; 2008 Feb; 126(1):17-25. PubMed ID: 18079013
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
Zhu X; Li F; Peng X; Zeng K
Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
[TBL] [Abstract][Full Text] [Related]
17. Piroxicam inhibits herpes simplex virus type 1 infection in vitro.
Astani A; Albrecht U; Schnitzler P
Pharmazie; 2015 May; 70(5):331-6. PubMed ID: 26062303
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).
Jin Y; Tong L; Ai P; Li M; Hou X
Int J Pharm; 2006 Feb; 309(1-2):199-207. PubMed ID: 16377106
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antiviral activity of acyclovir loaded into nanoparticles.
Cavalli R; Donalisio M; Bisazza A; Civra A; Ranucci E; Ferruti P; Lembo D
Methods Enzymol; 2012; 509():1-19. PubMed ID: 22568898
[TBL] [Abstract][Full Text] [Related]
20. Role of acyclovir gel in herpes simplex: clinical implications.
Seth AK; Misra A; Umrigar D; Vora N
Med Sci Monit; 2003 Jul; 9(7):PI93-8. PubMed ID: 12883465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
